Pharmaceutical Technology Europe-01-07-2011

January 10, 2011

How innovation is cushioning pharma's fall from the patent cliff.

January 07, 2011

During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market.

January 07, 2011

This month, our columnist Nathan Jessop discusses a topic that remains highly debated in Europe; direct to consumer (DTC) advertising.

January 07, 2011

Orally disintegrating tablets (ODTs) are growing in popularity and their market value could exceed $13 billion in sales by 2015, based on current global growth trends.

January 07, 2011

Direct-to-consumer (DTC) advertising is firmly entrenched in the US, but has historically been considered as an inappropriate means of communication in Europe for prescription-only medicines.

January 07, 2011

Iain Moore explains what progress has been made so far regarding EU plans to regulate excipients.

January 07, 2011

Biologics are large molecular weight molecules primarily formulated for parenteral administration; however, there are some smaller biomolecules that have been formulated for oral use.

January 07, 2011

Biopharmaceuticals commonly cannot be terminally sterilised, as such aseptic processing using sterilising grade filtration is essential.

January 07, 2011

UHPLC offers increased performance compared with HPLC, including shorter analysis times and increased sensitivity.

January 07, 2011

Excipients should be regulated to manage risk. Although, excipients are an integral part of a finished pharmaceutical product, the issue of regulation is complex.

January 07, 2011

The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.